AK Medical Holdings Inkomsten in het verleden
Verleden criteriumcontroles 1/6
De winst van AK Medical Holdings is gedaald met een gemiddeld jaarlijks percentage van -10.1%, terwijl de winst van de Medical Equipment -industrie jaarlijks groeide met 14.7%. De inkomsten zijn groeide met een gemiddeld percentage van 5.1% per jaar. Het rendement op het eigen vermogen AK Medical Holdings bedraagt 7.6% en de nettomarge bedraagt 17.1%.
Belangrijke informatie
-10.1%
Groei van de winst
-11.5%
Groei van de winst per aandeel
| Medical Equipment Groei van de industrie | 13.7% |
| Inkomstengroei | 5.1% |
| Rendement op eigen vermogen | 7.6% |
| Nettomarge | 17.1% |
| Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
Recent updates
AK Medical Holdings Limited (HKG:1789) Not Flying Under The Radar
Nov 18
AK Medical Holdings Limited's (HKG:1789) Intrinsic Value Is Potentially 92% Above Its Share Price
Aug 30Why We're Not Concerned Yet About AK Medical Holdings Limited's (HKG:1789) 25% Share Price Plunge
Jun 20It's Unlikely That Shareholders Will Increase AK Medical Holdings Limited's (HKG:1789) Compensation By Much This Year
Jun 11Returns On Capital At AK Medical Holdings (HKG:1789) Paint A Concerning Picture
May 27We Think AK Medical Holdings (HKG:1789) Can Stay On Top Of Its Debt
May 08Investors Appear Satisfied With AK Medical Holdings Limited's (HKG:1789) Prospects
Apr 21AK Medical Holdings Limited (HKG:1789) Analysts Are Reducing Their Forecasts For This Year
Apr 01AK Medical Holdings' (HKG:1789) Returns On Capital Not Reflecting Well On The Business
Jan 22Shareholders Should Be Pleased With AK Medical Holdings Limited's (HKG:1789) Price
Jan 04AK Medical Holdings (HKG:1789) Seems To Use Debt Rather Sparingly
Dec 12A Look At The Fair Value Of AK Medical Holdings Limited (HKG:1789)
Nov 09AK Medical Holdings (HKG:1789) Could Be Struggling To Allocate Capital
Sep 20AK Medical Holdings (HKG:1789) Could Easily Take On More Debt
Sep 03Investors Could Be Concerned With AK Medical Holdings' (HKG:1789) Returns On Capital
Jun 07Estimating The Fair Value Of AK Medical Holdings Limited (HKG:1789)
May 18Returns On Capital Signal Tricky Times Ahead For AK Medical Holdings (HKG:1789)
Feb 13Returns On Capital Signal Tricky Times Ahead For AK Medical Holdings (HKG:1789)
Nov 10Estimating The Fair Value Of AK Medical Holdings Limited (HKG:1789)
Sep 29Be Wary Of AK Medical Holdings (HKG:1789) And Its Returns On Capital
Aug 04Are Investors Undervaluing AK Medical Holdings Limited (HKG:1789) By 44%?
Jun 25There Are Reasons To Feel Uneasy About AK Medical Holdings' (HKG:1789) Returns On Capital
Apr 11Capital Allocation Trends At AK Medical Holdings (HKG:1789) Aren't Ideal
Oct 08Estimating The Intrinsic Value Of AK Medical Holdings Limited (HKG:1789)
Sep 20Analysts Are More Bearish On AK Medical Holdings Limited (HKG:1789) Than They Used To Be
Jul 27I Built A List Of Growing Companies And AK Medical Holdings (HKG:1789) Made The Cut
Jul 19AK Medical Holdings Limited (HKG:1789) Shares Could Be 39% Below Their Intrinsic Value Estimate
Jun 16The Returns On Capital At AK Medical Holdings (HKG:1789) Don't Inspire Confidence
Jun 01Opbrengsten en kosten
Hoe AK Medical Holdings geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 1,102 | 189 | 345 | 134 |
| 31 Mar 24 | 1,098 | 185 | 349 | 136 |
| 31 Dec 23 | 1,094 | 182 | 352 | 137 |
| 30 Sep 23 | 1,132 | 197 | 344 | 130 |
| 30 Jun 23 | 1,170 | 211 | 337 | 123 |
| 31 Mar 23 | 1,111 | 208 | 318 | 117 |
| 31 Dec 22 | 1,052 | 205 | 298 | 111 |
| 30 Sep 22 | 949 | 156 | 308 | 113 |
| 30 Jun 22 | 845 | 107 | 317 | 116 |
| 31 Mar 22 | 803 | 100 | 305 | 114 |
| 31 Dec 21 | 761 | 93 | 293 | 113 |
| 30 Sep 21 | 883 | 178 | 279 | 113 |
| 30 Jun 21 | 1,004 | 263 | 266 | 113 |
| 31 Mar 21 | 1,020 | 288 | 251 | 109 |
| 31 Dec 20 | 1,035 | 314 | 237 | 105 |
| 30 Sep 20 | 1,002 | 307 | 237 | 97 |
| 30 Jun 20 | 968 | 300 | 236 | 89 |
| 31 Mar 20 | 947 | 284 | 251 | 85 |
| 31 Dec 19 | 927 | 267 | 267 | 81 |
| 30 Sep 19 | 845 | 235 | 255 | 71 |
| 30 Jun 19 | 763 | 203 | 243 | 61 |
| 31 Mar 19 | 682 | 174 | 220 | 53 |
| 31 Dec 18 | 601 | 145 | 197 | 46 |
| 30 Sep 18 | 543 | 136 | 175 | 41 |
| 30 Jun 18 | 485 | 127 | 154 | 37 |
| 31 Mar 18 | 429 | 116 | 130 | 36 |
| 31 Dec 17 | 373 | 105 | 106 | 35 |
| 30 Sep 17 | 345 | 100 | 92 | 33 |
| 30 Jun 17 | 318 | 94 | 79 | 30 |
| 31 Mar 17 | 294 | 86 | 77 | 25 |
| 31 Dec 16 | 271 | 77 | 74 | 20 |
| 31 Dec 15 | 206 | 65 | 49 | 19 |
| 31 Dec 14 | 148 | 52 | 28 | 16 |
Kwaliteitswinsten: 1789 heeft hoge kwaliteitsinkomsten.
Groeiende winstmarge: De huidige netto winstmarges (17.1%) 1789 } zijn lager dan vorig jaar (18.1%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: De winst van 1789 is de afgelopen 5 jaar met 10.1% per jaar gedaald.
Versnelling van de groei: De winstgroei 1789 is het afgelopen jaar negatief geweest en kan daarom niet worden vergeleken met het 5-jarig gemiddelde.
Winst versus industrie: 1789 had het afgelopen jaar een negatieve winstgroei ( -10.7% ), waardoor het moeilijk is om te vergelijken met het branchegemiddelde Medical Equipment ( -4.3% ).
Rendement op eigen vermogen
Hoge ROE: Het Rendement op eigen vermogen ( 7.6% ) van 1789 wordt als laag beschouwd.